Depot injection. A depot injection is an injection, usually subcutaneous, intradermal, or intramuscular, that deposits a drug in a localized mass, called a depot, from which it is gradually absorbed by surrounding tissue. Such injection allows the active compound to be released in a consistent way over a long period.
The Vanquish TM is a tunable, focused bipolar radiofrequency device which is FDA-approved for deep tissue heating. The deep tissue heating preferentially focuses in on the fat layer, and causes it to shrink by causing most of the fat cells to die off.
Nashua Eye Associates already offers the a full compliment of dry eye therapies, including Lumenis IPL and Lipiflow. For more than a decade, Restasis has been the only prescription drop FDA approved for dry eye treatment. The following is from the FDA, announcing the approval of Xiidra. The medication has been approved, but not is not yet available in pharmacies. The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease, on Monday, July 11, 2016.